- In September 2022, Mama Mio U.S. Inc. introduced the Pink Tummy Rub Butter in collaboration with CoppaFeel to promote breast cancer awareness. This product supports pregnant women by enhancing skin elasticity and hydration to prevent stretch marks. This initiative combines skincare benefits with a social cause, reflecting a commitment to both maternal wellness and cancer awareness
- In September 2022, Frida Mom launched a new skincare line designed specifically for pregnant women in the United States. This line addresses the unique skin needs of expecting mothers, providing tailored care for delicate, changing skin. The launch signifies Frida Mom’s dedication to creating products that safely support women during their pregnancy journey
- In May 2022, Mirvie secured USD 90 million following the closure of its series B funding round, facilitating the advancement of the proprietary Mirvie RNA platform. This platform is groundbreaking in predicting preeclampsia and preterm births by decoding each pregnancy's unique biology months in advance. The funding supports both clinical and commercial progress, marking a step forward in prenatal health technology
- In August 2021, Expanscience introduced two innovative 100% organic products to support mental and physical well-being, aligned with its Corporate Social Responsibility efforts. Made with holy basil, known in Ayurvedic medicine for its healing properties, the products reflect the brand’s dedication to sustainability and ethical supply chains, sourcing holy basil responsibly from Thailand's Chiang Mai region
- In February 2021, Clarins began 2021 with the launch of 11 new products, following its evolution into a carbon-neutral brand in 2020. Embarking on an enhanced Corporate Social Responsibility journey, Clarins set a “care for people and the planet” initiative, aiming for B-corp certification by 2023 to further demonstrate its commitment to sustainable, ethical beauty practices
- In November 2020, Noodle & Boo unveiled the E-7 Collection, tailored for eczema-prone skin with scientifically advanced formulations using pure, healthful ingredients known for their organic healing properties. The E-7 Collection was recognized by the National Eczema Association, earning its Seal of Acceptance for effective, gentle eczema care, emphasizing Noodle & Boo’s focus on sensitive skin wellness
Frequently Asked Questions
The market is segmented based on Segmentation, By Treatment (Medication, Chemotherapy and Surgery), Types (Tubal Pregnancy, Non-tubal Ectopic Pregnancy and Heterotopic Pregnancy), Drugs (Methotrexate, Misoprostol and Others), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others) – Industry Trends and Forecast to 2032
.
The Global Extrauterine Pregnancy Treatment Market size was valued at USD 240.30 USD Million in 2024.
The Global Extrauterine Pregnancy Treatment Market is projected to grow at a CAGR of 9.79% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
